Efficacy and safety of lenvatinib in patients with recurrent hepatocellular carcinoma after liver transplantation-Reference-Cited by-同舟云学术

Efficacy and safety of lenvatinib in patients with recurrent hepatocellular carcinoma after liver transplantation

Published:2022-08-05 Issue:3 Volume:12 Page:2572-2579
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Bang Kyunghye¹²^ORCID,Casadei‐Gardini Andrea³,Yoo Changhoon¹^ORCID,Iavarone Massimo⁴,Ryu Min‐Hee¹,Park Sook Ryun¹,Kim Hyung‐Don¹,Yoon Young‐In⁵,Jung Dong‐Hwan⁵,Park Gil‐Chun⁵,Ahn Chul‐Soo⁵,Moon Deok‐Bog⁵,Hwang Shin⁵,Kim Ki‐Hun⁵,Song Gi‐Won⁵,Mazzarelli Chiara⁶,Alimenti Eleonora⁴,Chan Stephen L.⁷,De Giorgio Massimo⁸,Ryoo Baek‐Yeol¹,Lee Sung‐Gyu⁵

Affiliation:

1. Department of Oncology, Asan Medical Center University of Ulsan College of Medicine Seoul Republic of Korea

2. Division of Hemato‐Oncology, Department of Internal Medicine Chung‐Ang University Gwangmyeong Hospital Gwangmyeong Republic of Korea

3. Department of Medical Oncology Vita‐Salute San Raffaele University, IRCCS San Raffaele Scientific Institute Milan Italy

4. Division of Gastroenterology and Hepatology Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy

5. Division of Hepatobiliary Surgery and Liver Transplantation Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine Seoul Republic of Korea

6. Hepatology and Gastro‐Enterology Unit ASST Ospedale Niguarda Milan Italy

7. State Key Laboratory of Translational Oncology Department of Clinical Oncology, Sir YK Pao Centre for Cancer, The Chinese University of Hong Kong Hong Kong

8. Department of Gastroenterology Hepatology and Liver Transplantation, Papa Giovanni XXIII Hospital Bergamo Italy

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.5123

Reference31 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

3. Recurrence of hepatocellular carcinoma after liver transplant: Patterns and prognosis

4. Liver Transplantation for Hepatocellular Carcinoma: Five Steps to Prevent Recurrence

5. Managements of recurrent hepatocellular carcinoma after liver transplantation: A systematic review

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Effectiveness of First Line Lenvatinib Therapy in Advanced Hepatocellular Carcinoma: Current Insights;Pragmatic and Observational Research;2024-06

2. Commentary: Case Report: Lenvatinib for the treatment of recurrent hepatocellular carcinoma in people living with HIV: a report of two cases;Frontiers in Oncology;2024-04-05

3. Pushing the limits of treatment for hepatocellular carcinoma;Current Opinion in Organ Transplantation;2023-11-30

4. Therapeutic Approach to Post-Transplant Recurrence of Hepatocellular Carcinoma: Certainties and Open Issues;Cancers;2023-11-26

5. Sequencing Systemic Therapy in Hepatocellular Carcinoma;Current Treatment Options in Oncology;2023-10-16